Posted by Michael Wonder on 12 May 2021
DermaSensor granted FDA breakthrough device designation
11 May 2021 - FDA designation fast tracks getting cancer detection device in the hands of healthcare professionals
DermaSensor has been awarded breakthrough device designation by the FDA. The company expects its product to be the first ever FDA cleared or approved skin cancer detection device for primary care providers.
